-
Report details
-
19
Figures
-
66
Tables
-
Chapter One: Executive Summary
-
Scope & Methodology
-
About Kalorama Information
-
Chapter Two: Introduction
-
Chapter Three: Healthcare Trends
-
Overview
-
Demographic Trends
-
Global Population and Aging
-
Workforce Reduction
-
Addressing the Aging Trend
-
Emerging and Emerged Markets
-
Chapter Four: IVD Testing Segments
-
IVD Testing Trends
-
Segment Growth Projections
-
POC Testing
-
Clinical Chemistry
-
Immunoassays
-
Mass Spectrometry (Immuno)
-
Molecular Assays
-
Hematology
-
Coagulation
-
Conventional Microbiology
-
Blood Grouping/Typing
-
Histology/Cytology
-
Chapter Five: Global IVD Markets
-
General
-
North America
-
Mexico, Central & South America
-
Brazil
-
Mexico
-
Other Central & South America
-
Western Europe
-
France
-
Germany
-
Italy
-
Spain
-
United Kingdom
-
Other Western Europe
-
Eastern Europe
-
Russia
-
Other Eastern Europe
-
Asia/Pacific
-
China
-
Japan
-
Other Asian Countries and Territories
-
Middle East
-
Africa
-
Chapter Six: Point-of-Care (POC) Procedures
-
Global POC Procedure Volume by Test Type
-
POC Self Tests
-
Traditional Blood Glucose Monitoring Activities
-
Continuous Blood Glucose Monitoring
-
Pregnancy and Fertility Testing
-
Coagulation Testing
-
Fecal Occult Blood Testing
-
Drugs of Abuse Testing
-
H. Pylori Testing
-
HIV Testing
-
Infectious Disease
-
Cholesterol Testing
-
POC Urinalysis Testing
-
Other POC Self-Testing
-
POC Self-Testing Product Sales
-
Pricing Trends
-
POC Professional Testing
-
POC Professional Blood Glucose Testing Procedures
-
POC Professional Critical Care Testing
-
POC Fertility Testing
-
POC Professional Infectious Disease Testing
-
POC Professional Cardiac Marker Testing
-
POC Professional Cholesterol/Lipid Testing
-
POC Professional Coagulation Testing
-
POC Professional HbA1C Testing
-
POC Professional Hematology Testing
-
POC Professional Fecal Occult Blood Screening
-
POC Professional Drugs of Abuse Testing
-
POC Professional Urinalysis Testing
-
Other POC Professional Testing
-
POC IVD Product Sales
-
Pricing Trends
-
Chapter Seven: Clinical Chemistry Procedures
-
Types of Tests
-
General Chemistry
-
Blood Gases & Electrolytes
-
Urinalysis
-
Global Sales of Clinical Chemistry Products
-
Pricing Trends
-
Chapter Eight: Immunoassay Procedures
-
Technologies
-
Labeling Techniques
-
Enzyme Immunoassays
-
Fluorescence Polarization Immunoassays (FPIAs)
-
Radioimmunoassays (RIAs)
-
Testing Procedures & Product Sales
-
Cardiac Markers
-
Tumor Markers
-
Autoimmune Conditions
-
Allergy Conditions
-
Thyroid Conditions
-
Proteins
-
Anemia
-
Fertility Testing
-
Therapeutic Drug Monitoring
-
Vitamin D
-
Diabetes/HbA1c
-
Drugs of Abuse
-
Infectious Diseases
-
Instruments
-
Pricing Trends
-
Chapter Nine: Molecular Testing Procedures
-
Types of Test
-
Testing Technologies
-
Infectious Diseases
-
Blood Screening
-
Cancer
-
Transplant Matching
-
Thrombophilia SNPs
-
Inherited Diseases
-
Other Molecular Tests
-
Prenatal
-
Global Sales of Molecular IVD Products
-
Pricing Trends
-
Chapter Ten: Laboratory-Based Hematology Procedures
-
Types of Tests
-
Global Sales of Hematology Products
-
Pricing Trends
-
Chapter Eleven: Coagulation Testing Procedures
-
Types of Tests
-
Global Sales of Coagulation Products
-
Pricing Trends
-
Chapter Twelve: Microbiology Procedures
-
Types of Tests
-
ID/AST Automated Panels & Reagents
-
Manual Panels & Reagents
-
Blood Culture
-
Chromogenic Media
-
Rapid Microbiological Tests
-
Mass Spectrometry
-
Global Sales of Conventional IVD Microbiology Products
-
ID/AST Panels & Reagents
-
Blood Culture
-
Chromogenic Media
-
Rapid Microbiological Tests
-
Mass Spectrometry
-
Pricing Trends
-
Chapter Thirteen: Blood Grouping/Typing Procedures
-
Types of Tests
-
Blood Grouping/Typing Product Sales
-
Pricing Trends
-
Chapter Fourteen: Histology/Cytology Procedures
-
Types of Tests
-
Pap Tests
-
In Situ Hybridization Tests
-
Immunohistochemistry Tests
-
Traditional Non-Pap Stains
-
Circulating Tumor Cells
-
Flow Cytometry
-
Histology/Cytology IVD Product Sales
-
Pricing Trends
-
Chapter Fifteen: Company Profiles
-
Abbott Diagnostics
-
Recent Revenue History
-
Alere Acquisition Update and Point of Care
-
Core Lab
-
Hematology
-
Blood Banking
-
Infectious Diseases - Molecular
-
Diabetes
-
HIV Point of Care
-
i-STAT Business
-
Agilent Technologies
-
Recent Revenue History
-
Agilent in Genomics
-
Cytogenetic Analysis
-
Sequencing
-
Flow Cytometry
-
Companion Diagnostics - Dako
-
COVID-19
-
Becton, Dickinson and Company (BD)
-
Recent Revenue History
-
Cytology
-
Molecular Microbiology
-
Traditional Microbiology - ID/AST
-
Blood Culture
-
Hospital Acquired Infections
-
Blood Collection
-
Mass Spectrometry
-
Flow Cytometry
-
COVID-19
-
bioMérieux Inc.
-
Recent Revenue History
-
Traditional Microbiology
-
Blood Culture
-
Immunoassays
-
Mass Spectrometry
-
BioFire Diagnostics Business
-
COVID-19
-
Bio-Rad Laboratories, Inc.
-
Recent Revenue History
-
Blood Bank
-
Immunoassays
-
Danaher Corporation
-
Dexcom
-
DiaSorin
-
Recent Revenue History
-
Immunoassays
-
Molecular
-
COVID-19
-
Exact Sciences
-
Recent Revenue History
-
COVID-19
-
Hologic, Inc.
-
Recent Revenue History
-
PANTHER Molecular System
-
HIV Testing
-
Sexually Transmitted Infections
-
Infectious Diseases
-
Cytology
-
COVID-19
-
Illumina
-
Recent Revenue History
-
COVID-19
-
Ortho Clinical Diagnostics (Ortho)
-
Recent Revenue History
-
Blood Bank
-
Core Lab / Immunoassays
-
COVID-19
-
PerkinElmer, Inc
-
Recent Revenue History
-
Diagnostics
-
COVID-19
-
QIAGEN
-
Recent Revenue History
-
Tuberculosis
-
Precision Medicine / Companion Diagnostics
-
Molecular Microbiology
-
Prenatal Testing
-
Next Generation Sequencing
-
Liquid Biopsy
-
COVID-19
-
Roche Diagnostics
-
Recent Revenue History
-
Hematology
-
Core Lab
-
Immunoassays
-
HIV
-
Core Molecular
-
Digital PCR
-
Diabetes Care
-
Coagulation
-
cobas Liat System – POC
-
HPV
-
Blood Bank
-
Transplant Medicine
-
Cancer Companion Testing
-
COVID-19
-
Siemens Healthineers (Siemens)
-
Recent Revenue History
-
Core Lab
-
Immunoassays
-
Hematology
-
Molecular
-
Acute Care – POC
-
COVID-19
-
Sysmex Corporation
-
Recent Revenue History
-
Hematology
-
Coagulation
-
Urinalysis
-
Immunoassays
-
Flow Cytometry
-
Precision Medicine / Companion Test Diagnostics
-
Oncology
-
COVID-19
-
Thermo Fisher Scientific Inc.
-
Recent Revenue History
-
Immunoassays
-
Microbiology
-
Next Generation Sequencing
-
qPCR
-
Mass Spectrometry
-
COVID-19
-
Werfen
-
Recent Revenue History
-
Hematology
-
Advanced Cell Diagnostics (ACD)
-
Autoimmunity
|
IVD Procedure Volumes, 2021-2026
23 Mar 2022
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama Information’s IVD Test Procedure Volumes, 2021-2026 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business planner.
The report estimates IVD test procedure volume and IVD pricing for the following segments:
- Worldwide IVD Market and Test Volume
- Point-of-Care (POC) Market and Test Volume
- Clinical Chemistry Market and Test Volume
- Molecular Market and Test Volume
- Hematology Market and Test Volume
- Coagulation Market and Test Volume
- Microbiology Market and Test Volume
- Blood Banking Market and Test Volume
- COVID-19 Market and Test Volume
- Histology/Cytology Market and Test Volume
- Immunoassay Market and Test Volume
- IVD Testing Segments and Global IVD Markets
IVD Test Procedure Volumes, 2021-2026 includes profiles of the top IVD market competitors, looking in detail where possible at procedural volume by type. The companies covered are the following:
- Abbott Laboratories
- Agilent Technologies
- Becton, Dickinson and Company (BD)
- bioMérieux Inc.
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Dexcom
- DiaSorin
- Exact Sciences
- Hologic, Inc.
- Illumina
- Ortho Clinical Diagnostics (Ortho)
- PerkinElmer, Inc.
- QIAGEN N.V.
- Roche
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Werfen
Page Count: 309
|
More information about this product
Other Users Also Viewed
23 Mar 2022
What’s Driving Growth in the IVD Market in 2022?
What Major Trends are Affecting the Market in 2022?
How Has COVID-19 Impacted and Continued to Impact the Market in 2022?
What Product Trends and New Developments Will Shape the IVD Market in 2022?
Diagnos…
|